SCHEMBL3759213

SCHEMBL3759213

CC1(C)CC(=O)c2sc(N3CCOCC3)c(C(=O)NCc3ccccn3)c2C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 2/20 0.46
KMT2A Q03164 1/20 0.45
ALDH1A1 P00352 4/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
CYP1A2 P05177 1/20 0.43
POLB P06746 2/20 0.41
TSHR P16473 3/20 0.41
PTPN11 Q06124 1/20 0.40
PKM P14618 3/20 0.40
KDM4E B2RXH2 3/20 0.40
LMNA P02545 2/20 0.40
HTT P42858 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
RAB9A P51151 1/20 0.39
HPGD P15428 1/20 0.39
PIK3CD O00329 1/20 0.39
PIK3CB P42338 1/20 0.39
PIK3CG P48736 1/20 0.39
NPC1 O15118 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4224851 0.87 ALDH1A1 (0.43) PIK3CAALDH1A1KDM4ELMNAHTT
SCHEMBL3761666 0.85 KMT2A (0.48) PIK3CAKMT2AALDH1A1L3MBTL1CYP1A2
SCHEMBL3762615 0.80 CNR2 (0.42) PIK3CAALDH1A1L3MBTL1RAB9APIK3CD
SCHEMBL3766924 0.75 PIK3CD (0.50) PIK3CAALDH1A1L3MBTL1POLBKDM4E
SCHEMBL3760327 0.75 PIK3CA (0.50) PIK3CAALDH1A1L3MBTL1POLBKDM4E
SCHEMBL3757634 0.74 PIK3CD (0.47) PIK3CAKMT2AALDH1A1L3MBTL1POLB
SCHEMBL3759845 0.74 PIK3CA (0.49) PIK3CAKMT2AALDH1A1L3MBTL1POLB
SCHEMBL3766043 0.73 PIK3CA (0.41) PIK3CAALDH1A1L3MBTL1POLBTSHR
SCHEMBL3764646 0.73 MAPK1 (0.47) PIK3CAALDH1A1GAAMAPT
SCHEMBL3763693 0.73 GABRA1 (0.48) PIK3CAKMT2AALDH1A1L3MBTL1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA PIK3CA 3/4885KMT2A 2175/4885ALDH1A1 3061/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.